Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Aptevo Therapeutics Inc. Common Stock, par value $0.001 per share (APVO).
- Disclosed ownership: 9.1%.
- Date of event: 16 Sep 2025.
Point72 Asset Management, L.P. - 16 Sep 2025 SCHEDULE 13G Report for Aptevo Therapeutics Inc. Common Stock, par value $0.001 per share (APVO)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- APVO
- Shares outstanding
- 3,296,088 shares
- Disclosed Ownership
- 299,944 shares
- Ownership
- 9.1%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Sep 2025, 17:26:05 UTC
- Date of event
- 16 Sep 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 9.1% ownership in Aptevo Therapeutics Inc. Common Stock, par value $0.001 per share (APVO) on 16 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Sep 2025, 17:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 9.1% | 299,944 | 0 | 299,944 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 9.1% | 299,944 | 0 | 299,944 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 9.1% | 299,944 | 0 | 299,944 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |